HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe.

about

HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe.

Item

http://www.wikidata.org/entity/Q50052129

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

HIV-1 Drug Resistance and Thir ...... cond-Line Therapy in Zimbabwe.

@en

HIV-1 Drug Resistance and Thir ...... cond-Line Therapy in Zimbabwe.

@nl

type

Item

label

HIV-1 Drug Resistance and Thir ...... cond-Line Therapy in Zimbabwe.

@en

HIV-1 Drug Resistance and Thir ...... cond-Line Therapy in Zimbabwe.

@nl

prefLabel

HIV-1 Drug Resistance and Thir ...... cond-Line Therapy in Zimbabwe.

@en

HIV-1 Drug Resistance and Thir ...... cond-Line Therapy in Zimbabwe.

@nl

P1476

HIV-1 Drug Resistance and Thir ...... cond-Line Therapy in Zimbabwe.

@en

P2093

Cleophas Chimbetete

http://www.w3.org/2001/XMLSchema#string

Janne Estill

http://www.w3.org/2001/XMLSchema#string

Olivia Keiser

http://www.w3.org/2001/XMLSchema#string

P2860

HIV and Adolescents: Guidance for HIV Testing and Counselling and Care for Adolescents Living With HIV

Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa

Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa

Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data

An affordable HIV-1 drug resistance monitoring method for resource limited settings

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.

Factors affecting adherence to antiretroviral therapy.

Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.

Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India.

Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa

P304

ofy005

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/OFID/OFY005

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29435471

http://www.w3.org/2001/XMLSchema#string

P921

An tSiombáib

P932

5801603

http://www.w3.org/2001/XMLSchema#string